<DOC>
	<DOCNO>NCT01322204</DOCNO>
	<brief_summary>The purpose study determine absorption bioavailability codeine relation postnatal ( PNA ) postconceptional ( PCA ) age ; determine parent drug ( codeine ) , active metabolite , formation rate ratios relation PCA PNA ; identify relevant genetic polymorphism opioid metabolism study population potential relationship biodisposition pharmacodynamic effect codeine . The study population intubate mechanically ventilated infant equal great 26 week gestational age birth le 4 week postnatal age .</brief_summary>
	<brief_title>Codeine Mechanically Ventilated Neonates</brief_title>
	<detailed_description>This proposal origins large initiative elucidate pharmacological basis interindividual difference observe opioid responsiveness . Gaps knowledge relate opioid disposition newborn need addressed complete design require overarch initiative age could treat continuous variable within context PK , PD PG determinants.This proposal design generate preliminary data address two issue . First , newborns absorb enterally administer codeine ability determine PCA PNA age ? The second relate ability newborn infant catalyze reaction require metabolically activate codeine morphine . The latter also evaluate within context PCA versus PNA age . These data fill information gap must address large initiative move forward , also provide platform serious study ontogeny certain pharmacokinetic process may prove critical understanding newborn drug disposition . In way , codeine provide important insight concern ontogeny drug disposition permit determination relative importance PCA versus PNA age functional expression process .</detailed_description>
	<mesh_term>Codeine</mesh_term>
	<criteria>Neonates â‰¥ 26 week PCA receive mechanical ventilation painful procedure eligible participation study Subject 's parent/legal guardian must give write informed consent prior study participation Subject receive opioid analgesia therapy base caregiver determination . The ideal patient receive morphine . Must able receive enteral dose codeine . Known hypersensitivity morphine , fentanyl , codeine Patients ALT concentration &gt; 2x upper limit normal age clinical evidence hepatic failure Patients serum creatinine concentration &gt; 2x upper limit normal age clinical evidence renal failure Patients NPO Babies bear maternal drug abuse . Total serum bilirubin level &gt; 10 mg/dl 170 umol/L .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Days</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>codeine , neonate , pediatric pharmacology</keyword>
</DOC>